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ABSTRACT 
 
Examining the Effects of D-Amino Acids on Translation 
 
Rachel C. Fleisher 
 
The ribosome is responsible for mRNA-templated protein translation in all living 
cells. The translational machinery (TM) has evolved to use 20 amino acids each esterified 
onto one of several tRNA bodies. While the active site of the ribosome, known as the 
peptidyl transferase center (PTC), is able to handle a remarkable amount of substrate 
diversity, many classes of unnatural amino acids are not compatible with the TM. For 
example, in the field of unnatural amino acid mutagenesis, the site-specific incorporation 
of biologically useful amino acids into proteins, such as fluorophores, has often proven to 
be unfeasible. This runs counter to the accepted notion that the ribosome is blind to the 
structure of the amino acid and is capable of accepting any amino acid as long as the 
mRNA codon: tRNA anticodon pairing is correct.  
Two studies by our group set out to test the hypothesis that the ribosome can 
indeed discriminate the structure of the amino acid. Using a fully purified E. coli 
translation system, the first study showed that natural amino acids misacylated onto fully 
modified but non-native tRNAs show small but reproducible effects on the steps of 
aminoacyl-tRNA (aa-tRNA) selection. The second study, in which I participated, utilized 
D-aa-tRNAs in the same E. coli translation system to study how amino acids of the 
inverted stereochemistry to those found in ribosomally-synthesized proteins affect 
translation elongation. We showed that these unnatural substrates serve as peptidyl 
acceptors but once translocated into the P-site of the ribosome, fail as peptidyl donors and 
stall translation elongation by inactivating the PTC. The motivation of my work has been 
to further characterize the effects of D-aa-tRNAs on translation elongation.  
To this end, I examined how the PTC is affected structurally and functionally by 
the presence of ribosomal substrates containing D-amino acids. Chapter one contains an 
introduction to this work. Chapter two describes chemical probing experiments that 
demonstrate that the presence of peptidyl-D-aminoacyl-tRNAs in the P-site of the 
ribosome allosterically modulates the secondary structure of ribosomal exit tunnel 
nucleotides A2058 and A2059. Chapter three describes how the reactivity of peptidyl-
D-aminoacyl-tRNAs to form tripeptides is highly dependent on the identity of the amino 
acid it is reacting with; protein yields can be close to what is obtained with natural amino 
acids or almost completely abolished. Chapter four contains the methods used to do this 
research. From the observations presented here as well as from the work of other 
laboratories, a picture of the PTC emerges in which the pairing of the A- and P- site 
substrates is integral in either promoting or suppressing catalysis by the PTC. This work 
has implications for the field of unnatural amino acid mutagenesis, particularly for 
strategies to improve the incorporation of interesting unnatural amino acid by the 
ribosome. In addition, this work adds an important aspect to the growing body of 
knowledge of ribosome stalling at the PTC. 
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1.1 Chapter Outlook 
Tremendous progress has been made towards incorporating unnatural amino acids 
site-specifically into proteins. However, many important classes of unnatural amino acids 
are poorly tolerated by the TM. In order to understand what step of translation might be 
affected by unnatural amino acids, we begin by reviewing some fundamental mechanistic 
aspects of translation elongation. We then discuss cases in which unnatural aa-tRNAs are 
poorly incorporated into proteins.  
There is already strong evidence that in the case of D-amino acids, P site-bound 
pepidyl-D-aa-tRNAs affect the proper functioning of the PTC, where peptide bond 
formation takes place. Therefore, in order to gain further mechanistic insight into this 
phenomenon, this chapter focuses on the mechanism of peptide bond formation, how the 
aa-tRNA substrate affects translation as well as mechanisms of translation stalling that 
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1.2 The genetic code and the central dogma of molecular biology 
Following the elucidation of the three dimensional structure of DNA in 1953 (1), 
a series of discoveries established the rules governing the genetic code (2). These 
findings along with the landmark early discoveries of Avery, Chargaff and others, proved 
that DNA, not protein, is the hereditary material of life. The rules of the genetic code are 
all conserved across all living organisms.  
The protein coding genetic information is encoded by the deoxyribonucleic acid 
bases adenine, guanine, thymine and cytosine in non-overlapping three-base 
combinations known as codons. The combinations of bases give rise to 64 unique codons, 
each of which corresponds to one of the 20 amino acids or one of three stop codons. The 
genetic code is described as degenerate because multiple codons can represent a single 
amino acid. Genes contain the information for the synthesis of proteins that perform the 
functions necessary to sustain life.  
In 1970, Crick articulated what came to be known as the Central Dogma of 
Molecular Biology (3). The information stored in DNA must first be transferred to an 
intermediate polymer of RNA, known as mRNA, from which it is used as a template to 
synthesize protein (Figure 1.1). This information flow described in the Central Dogma as 
well as the rules of the genetic code are all conserved across all forms of life.  
 




Figure 1.1 Depiction of the central dogma of molecular biology. 
 
The mRNA-templated synthesis of proteins is known as translation and is 
catalyzed by the ribosome aided by several protein translation factors. An adaptor RNA 
molecule called tRNA contains a three-nucleotide sequence termed the anticodon that 
forms Watson-Crick base pairs with the codons in the mRNA sequence. In addition, 
specific aminoacyl tRNA synthetases (aaRSs) charge tRNAs with their cognate amino 
acid at their 3’ end; thus the tRNA serves as a link between the nucleic acid input and a 
unique protein output. Proper interpretation of the genetic code relies on the fidelity of 
the aaRSs (4, 5). 
1.3 The Adaptor Hypothesis 
As early as 1958, Crick (6) and Hoagland (7) separately hypothesized that nucleic 
acid adaptor molecules base pair with the genetic template by means analogous to base 
pairing in the DNA double helix, and deliver amino acids to the growing polypeptide 
chain. Remarkably, this hypothesis preceded the understanding of the role of the 
ribosome, and the discovery of both mRNA (8) and tRNA (originally termed sRNA) (9). 
The Adaptor Hypothesis, with its focus on the hydrogen-bonding interactions between 
DNA RNA Protein
Transcription Translation
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the tRNA anticodon and the mRNA codon, laid the groundwork for the view that the 
tRNA body and the amino acid it carries, are passive players during translation.  
 Proof for the Adaptor Hypothesis was provided in a highly influential 1962 
publication by Chapeville, et al (10).  The authors utilized Raney Nickel to generate 
misacylated Alanine on tRNA Cysteine (Ala-tRNACys) from Cys-tRNACys by reductive 
desulfhydration. This allowed them to test whether the codon determines the 
incorporation of an amino acid at a certain position (Figure 1.2).  
 
Figure 1.2: Schematic of the experiment performed by Chapeville et al. The grey body 
represents a Cys adaptor molecule with the reduced alanine in orange. 
  
They then compared the rate and yield of incorporating Cys-tRNACys to that of Ala-
tRNACys in an E. coli cell extract system containing a poly-UG mRNA template. The 
result strongly suggested that alanine was being incorporation in response to a cysteine 
codon; hydrolysis of the polypeptide product followed by electrophoresis confirmed it. 
This, along with several follow-up experiments with misacylated tRNAs demonstrated 
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that amino acids could be reassigned to different codons by misacylation of an amino 
acid onto a non-native tRNA.  
 Collectively, these results have been widely understood to mean that the ribosome 
is blind to the structure of the amino acid. The fidelity of protein synthesis has been 
attributed to the highly specific aminoacylation of tRNAs by the aminoacyl-tRNA 
synthetase enzymes followed by a multistep aa-tRNA decoding process of the tRNA 
anticodon by the TM. Crick, in a 1963 review of translation, stated: “the amino acid goes 
where the sRNA directs it and has no further control of its destination” (11). This view of 
the amino acid in protein translation continues to be the textbook standard. 
1.4 Translation by the Ribosome 
1.4.1 The ribosome and translation elongation 
The ribosome is a highly conserved, massive ribonucleoprotein (~2.5x106 Da) that 
serves as a platform for coordinating the mRNA with cognate aa-tRNAs as well as for 
catalyzing peptide bond formation between the an incoming aa-tRNA with the growing 
polypeptide chain.  
In prokaryotes and archaea, the ribosome is denoted the 70S, so-called because of 
its sedimentation coefficient. The ribosome contains two subunits that are of unequal size 
(12). The small 30S binds the mRNA and contains the decoding center, where the 
ribosome matches a tRNA anticodon with its cognate codon in a process called aa-tRNA 
selection. It is composed of a single chain of ribosomal rRNA (rRNA), termed the 16S, as 
well as ribosomal proteins. The large 50S subunit contains the peptidyl transferase center 
and is where peptide bond formation is catalyzed between an incoming aa-tRNA and the 
growing polypeptide chain. It contains two molecules of rRNA, the 23S and 5S, as well 
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as ribosomal proteins. Both subunits contain three distinct binding sites for tRNA: the 
acceptor site (A-site) for incoming aa-tRNA, the peptidyl-tRNA site (P-site) which 
harbors the tRNA carrying the growing polypeptide chain and the exit site (E-site) 
containing deacylated tRNA (Figure 1.3). 
 
Figure 1.3:  The structure of the ribosome. (PDB file 4V5C) 
 
As in all polymerization reactions, protein synthesis by the ribosome is made up 
of three steps: initiation, elongation and termination. In prokaryotes, initiation is mediated 
by initiation factors IF-1, IF-2 and IF-3 and involves the assembly of the ribosome onto 
the mRNA around the start codon, usually AUG, which codes for methionine. The 
initiation factors aid in the assembly of the 50S and 30S subunits around the start codon 
and in the selection of the initiator tRNA, a formylated methionine on a unique initiator 
tRNA that encodes methionine (fMet-tRNAfMet).  
Once the initiation complex is formed, the elongation cycle can proceed. In the 
first step of the elongation cycle, aa-tRNA selection, aa-tRNA is delivered to the 
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ribosome in a ternary complex with the translation factor EF-Tu bound to GTP. A series 
of steps based on the interactions of the mRNA codon and tRNA anticodon ensures that 
cognate aa-tRNA is selected and accommodated into the A-site of the ribosome. Once 
accommodated, the amine moiety of the A-site tRNA is poised for nucleophilic attack of 
the acyl bond of the P-site tRNA and the step of peptide bond formation occurs. As a 
result, the entire polypeptide chain is transferred to the A-site tRNA and the P-site tRNA 
is deacylated; thus, the A-site tRNA is known as the peptidyl acceptor and the P-site 
tRNA is known as the peptidyl donor. In the third step of elongation, the translation 
factor EF-G mediates A-site tRNA translocation to the P site and the deacylated P-site 
tRNA translocation to the E site with concomitant movement of the mRNA by one 
codon. The A site is now vacant with the new codon of the mRNA exposed, allowing the 
elongation process to continue until the full protein has been synthesized (Figure 1.4).  
 












































Once protein synthesis is complete, the mRNA encodes one of three stop codons 
in the A site. Release factor RF-1 recognizes the stop codons UAA and UAG and RF-2 
recognizes the stop codons UAA and UGA. RF-3 helps catalyze the release of RF-1 and 
RF-2 from the ribosome after peptide release.  
1.4.2 Amino-acyl tRNA selection 
Translation errors rates in vivo have been estimated to be approximately 1 in 10-3-
10-4 , which has largely been attributed to the EF-Tu-mediated aa-tRNA selection, with a 
smaller contribution coming from fidelity of the aaRSs (13). While discrimination of 
cognate from non-cognate tRNAs by the ribsome can be explained by differences in free 
energy of binding (ΔΔG), as early as 1963 it became apparent that discrimination of 
cognate codons from near-cognate codons by the ribosome could not be accounted for by 
differences in Watson-Crick base pairing energies (14). In order to achieve the error rates 
of 10-3-10-4 that have been measured in vivo, a ΔΔG of 18-24 kJ/mol would be needed 
(13), which cannot be obtained by base-pairing alone. 
 Biochemical (15–17), structural (18–20), and dynamic studies (21, 22) have all 
sought to resolve the question of how the ribosome is able to discriminate between 
cognate, near-cognate and non-cognate tRNAs. A kinetic proofreading hypothesis was 
proposed in which the overall selectivity of a two-step process is increased when the 
steps are separated by an irreversible step (23, 24). The increase in selectivity comes from 
the tRNAs having to successfully navigate two separate selection steps. This was borne 
out in biochemical experiments, in which the two step of aa-tRNA selection, initial 
selection and proofreading, are separated by irreversible GTP hydrolysis by EF-Tu on the 
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ribosome (Figure 1.4) (25, 26).  
 
Figure 1.5: Kinetic scheme for aa-tRNA selection. Reproduced with permission from 
Cochella, L. et al. Science, 308, 1178 (2005) 
 
Detailed kinetic studies revealed that the rates of GTPase activation and 
accommodation are accelerated for cognate over near-cognate tRNA, which suggested an 
induced fit mechanism (16). Indeed, crystal structures show a large conformational 
change in the decoding center of the ribosome upon binding of cognate tRNA but not 
near-cognate tRNA (18). In those structures, 16S rRNA nucleotides A1492 and A1493 
are flipped out of helix 44 and, along with nucleotide G530, make extensive contacts with 
the minor groove of the codon:anticodon helix. In addition, the 30S subunit closes around 
the cognate codon:anticodon (19). Neither of these conformational changes was observed 
for the near-cognate complex. Interestingly, the aminoglycoside antibiotic paromomycin 
induces the same conformational changes (19, 27) and shows the same acceleration of the 
rates of GTPase activation and accommodation (28). Further kinetic studies determined 
that the ribosome accelerates these rates in response to the conformational changes and 
does not differentially stabilize the cognate over the near-cognate complex (29).  
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1.4.3 Peptide bond formation 
1.4.3.1 Proposed mechanisms of peptidyl transfer 
Following accommodation of the aa-tRNA into the A site, peptide bond formation 
takes place. Comparison of the rates of uncatalyzed peptide bond formation vs. ribosome-
catalyzed reaction shows a rate enhancement of 105 for the ribosome-catalyzed reaction 
(30). The active site is composed of ribosomal RNA (rRNA); thus the ribosome is a 
ribozyme. Though proteins L4 and L27 in bacterial ribosomes are in proximity to the 
reacting moieties (31), they are not absolutely required, nor are these proteins conserved 
over all forms of life (32–34) . Early experiments implicated an acid-base mechanism for 
peptide bond formation via nucleotide A2451, though mutational studies proved this 
mechanism to be incorrect  (35, 36).  
Analysis of contributions of enthalpy and entropy of activation demonstrated  that 
the rate enhancement of peptide bond formation is due to a large reduction in activation 
entropy, leading to the idea of the ribosome as an “entropy trap” (30). It has been 
suggested from crystallographic data that the primary means by which the entropic 
penalty is reduced is by the precise alignment of the A- and P- site substrates (37). 
Molecular dynamic (MD) simulations of peptidyl transfer, however, suggested that 
catalysis by the ribosome occurs because of a preorganized hydrogen bonding network 
within the peptidyl transferase center with the P-site 2-OH of A76 acting as a proton 
shuttle (38). These MD simulations were bolstered by biochemical experiments in which 
a dramatic loss of peptidyl transfer was observed when the P-site 2-OH of A76 was 
mutated to a hydrogen or fluorine; that result suggested that peptidyl transfer is substrate-
assisted (39). This result was refuted by Sprinzl and colleagues, who showed that they 
could synthesize full-length protein with a suppressor tRNA that lacked the 2’-OH at A76 
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(40). This contradiction was resolved when it was determined that lack of the 2’-OH at 
A76 causes a slow rearrangement of the PTC by which the peptidyl-tRNA becomes 
inaccessible to nucleophilic attack by the A-site aa-tRNA (41). Interestingly, while 
mutation of A2451 to another nucleotide did not substantially affect peptidyl transfer, 
substitution of the 2’-ribose group of A2451 to a deoxyribose group (2’-OH to 2’-H) led 
to a dramatic loss of activity, suggesting that nucleotide A2451 does contribute to 
peptidyl transfer (42). Finally, two kinetic isotope effect studies did indeed show that a 
proton shuttle mechanism is present, though the studies differed in their proposed 
mechanisms (43, 44).  
Yet, there are many studies that are consistent with the notion that substrate 
alignment is necessary for peptidyl transfer. The conserved 3’-CCA ends of tRNAs 
makes contacts with rRNA in both the A-loop and the P-loop of the 50S subunit. 
Specifically, C75 of the A-site aa-tRNA base pairs with PTC nucleotide G2553 (45) and 
C74 of the P-site tRNA base pairs with PTC nucleotide G2252 (46), both of which are 
necessary for peptidyl transfer. Crystal structures obtained with minimal ribosome A-site 
substrates puromycin (pmn), C-pmn and CC-pmn were compared to assess 
conformational differences. These structures revealed an induced-fit mechanism: as the 
minimal substrate begins to more closely mimic a true tRNA and make key contacts 
(where CC-pmn mimics the conserved 3’-CCA-amino acid end of tRNA and pmn mimics 
the 3’-A-amino acid), rRNA nucleotides 2583-2585 and nucleotide U2506 shift to help 
orient the P-site ester moiety, making it more accessible to the α-amine of the A-site for 
nucleophilic attack (Figure 1.5) (47).  




Figure 1.6: Conformational changes observed in the PTC upon binding successively 
longer A-site mimics. As the acceptor makes more contacts within the A site, 
conformational changes of the rRNA nucleotides as well as the donor mimic allow for 
optimal alignment of nucleophilic attack (PDB files 1VQ6 and 1VQ7) 
 
 
When an A-site substrate is not present, the rRNA nucleotides are oriented in a manner 
that shields the peptidyl tRNA from being hydrolyzed by water. These conformational 
changes were likewise observed in structures containing full-length aminoacyl-tRNAs 
(31). Another study made mutations to the four rRNA nucleotides that are in hydrogen 
bonding distance to the reacting A- and P- site moieties.  




Figure 1.7: The inner shell nucleotides modeled with a transition-state analog. 
Reproduced with permission from Youngman et al., Cell, 117, 589 (2004) 
 
These results, showed that the peptidyl transfer reaction was not substantially affected 
when full-length aa-tRNAs were used but was affected when pmn was used. In addition, 
they found that these mutations inhibited peptide release. This led them to conclude that 
there are two conserved layers of nucleotides at the PTC; an inner layer that is needed for 
peptide release and an outer layer makes contacts with the full-length aa-tRNA to 
promote peptidyl transfer (48). Thus, proton shuttle, substrate alignment, substrate-
assisted catalysis and induced fit mechanisms all contribute to the catalysis of peptidyl 
transfer by the ribosome.  
1.4.3.2 Rates of peptidyl transfer and substrate identity 
The rate of peptidyl transfer (kpep) is difficult to measure because the rate of 
accommodation (on the order of 7 s-1) which immediately precedes peptide bond 
formation is rate limiting for peptidyl transfer (15). The rate of peptide bond formation 
has been measured at 20 s-1 (49) but with full-length unmodified Phe-tRNAPhe has been 
estimated to be 300 s-1 (50). Rates with puromycin have been measured between 12 and 
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50 s-1 (51) and the differences in these rates can possibly be attributed to deficiencies in 
binding to the A site by pmn.  
Several early papers demonstrated, using puromycin analogs, that the yield from 
the peptidyltransfer reaction is affected by the nature of the peptidyl acceptor (52, 53). 
Rodnina and colleagues showed that the rate of peptidyl transfer with puromycin and 
differing P-site donors vary considerably but that the rate using full-length substrate was 
measured at 7 s-1, the rate of accommodation (54). Comparison of  kpep using 10 different 
aa-tRNAs reacting with fMet-tRNAfMet corroborated that accommodation is rate-limiting 
and that the rate does not differ with the identity of the aa-tRNA (55). However, kpep 
when Pro-tRNAPro served as a peptidyl acceptor was 3-6 times slower than that for Phe-
tRNAPhe, ostensibly because of the decreased nucleophilicity of an imino acid (56).  
1.4.4 Translocation 
Following peptide bond formation, the P-site tRNA is deacylated and the growing 
polypeptide chain is acylated on the A-site tRNA. This state is known as the 
pretranslocation (PRE) complex and transition to the posttranslocation (POST) complex 
involves the movement of the tRNAs to the adjacent sites as well as the movement of the 
mRNA by one codon, catalyzed by EF-G. That translocation is a multistep process first 
came to light through chemical protection experiments done by Moazed and Noller (57). 
The chemical modification and protection patterns showed that the A- and P- site tRNAs 
adopt an ‘intermediate’ comformation in the PRE state. This conformation, termed the 
hybrid state, is defined by the 3’-CCA end of the A-site tRNA occupying the P site while 
the anticodon in the 30S continues to occupy the A site (A/P state) and the 3’-CCA end 
of the P-site tRNA moves into the E site while the anticodon continues to occupy the P 
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site (P/E). In constrast, the classical state is defined by tRNAs in the A/A and P/P 
conformation.   
The large scale movement of the tRNAs and mRNA require concomitant large 
conformational changes of the ribosome (58). The PRE complex is in equilibrium 
between two global conformational states: Global State I (GS1) and Global State II 
(GS2). GS2 is characterized by a ratchet-like rotation of the 30S subunit relative to the 
50S (59) as well as movement of the L1 stalk by 20Å towards the P site (60), with 
contact between the L1 stalk and P-site tRNA being maintained through the duration of 
the PRE state (61). Both the intersubunit rotations as well as the movement of the L1 
stalk only occur when the P-site tRNA is deacylated (60, 62, 63). EF-G binds the 
ribosome preferentially when tRNAs are in the hybrid state (64) and once bound, 
ribosome-stimulated GTP hydrolysis by EF-G takes place. Conformational changes in 
EF-G to the GDP-bound form lead to a series of events that cause tRNA-mRNA 
translocation including the decoding center becoming decoupled from the tRNA and 
mRNA and reversion of the rotated 30S back to its original position relative to the 50S.  
The hybrid state occurs spontaneously after peptide bond formation (65) and the 
tRNAs fluctuate between the classical and hybrid states in the PRE complex both in the 
presence and absence of EF-G and independent of GTP hydrolysis (21, 66). This led to 
idea, originally proposed by Spirin, that the ribosome acts as a Brownian motor where the 
thermal, intrinsic fluctuations of the tRNAs are rectified to unidirectional movement by 
EF-G•GTP (67). Single molecule FRET (smFRET) experiments with labels on different 
locations of the ribosome and tRNAs provided evidence that the tRNA fluctuations from 
classical to hybrid in the PRE complex correspond to the large scale movements of GS1 
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and GS2 respectively (68–70). Interestingly, the antibiotic sparsomycin (71), as well as 
several other antibiotics that bind the A site (72), are able to induce translocation 
independently of EF-G. Using smFRET, they found that the antibiotics act as ligands that 
convert the thermally-driven dynamics of the PRE complex into productive translocation, 
providing further evidence that the ribosome is a Brownian ratchet that uses the ligand 
binding to direct its intrinsic dynamics into unidirectional motion.  
1.5 Challenges to the Adaptor Hypothesis 
The Adaptor Hypothesis was truly impressive in its prediction of tRNA. 
However, the notion that only the codon:anticodon pairing is important while the amino 
acid and tRNA body are passive is an incomplete picture of how aa-tRNA and peptidyl-
tRNA interact with the ribosome. Indeed, the complexity of the interactions of the tRNA 
body, the amino acid aa-tRNA and the polypeptide chain of peptidyl-tRNA with the TM 
and with each other is far beyond what was ever envisioned by the Adaptor Hypothesis. 
Thirty years of unnatural amino acid mutagenesis technology has shown that not all 
amino acids are tolerated by the TM. With techniques such as ribosome profiling that 
report on translational pausing/arrest in vivo (73), we now know that there is considerable 
variability in translation elongation that can occur as a result of the amino acid sequence 
in the ribosome (74–76) and nascent chain-dependent arrest (77). Below, some 
challenges to the Adaptor Hypothesis are discussed. 
1.5.1 Unnatural Amino Acid Mutagenesis 
The ability to site-specifically incorporate unnatural amino acids, whether the side 
chain or the backbone, has revolutionized the study of protein structure and mechanism 
(78–81). While the underlying concept of unnatural amino acid mutagenesis is based on 
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the idea that the ribosome is blind to the amino acid, work done in this field provides 
some of the strongest indirect evidence that the structure of the amino acid can interfere 
with the proper functioning of the TM.  
The original challenge of this field was the synthesis of misacylated tRNAs. 
Technology introduced in the 1980s used an in vitro transcribed suppressor tRNACUA 
lacking a 3’-CA and utilized T4 RNA ligase to ligate a chemically synthesized 
aminoacyl-dCA (aa-pdCpA) (82, 83). This tRNA was then introduced into a cell extract 
along with a plasmid containing a TAG nonsense mutation in the protein of interest. 
Using this technology, the Schultz laboratory studied the incorporation of several 
unnatural amino acids misacylated onto the same tRNA at the conserved F66 of β-
lactamase. They found significant differences in the amount of protein synthesized 
depending on the unnatural amino acid being incorporated; whereas p-NO2-Phe-tRNACUA 
was incorporated with yields that mirrored that of the wild-type Phe-tRNACUA, β-
lactamase with D-Phe-tRNACUA was undetected (84). Even misacylation of suppressor 
tRNAs with natural amino acids produced considerable differences in yield (85). For 
example,  
A major issue with these early experiments was that the cell-free extracts that 
were used contained release factors. These release factors were able to compete with the 
suppressor tRNAs and terminate translation, thereby reducing the yield of the protein 
synthesized with the unnatural amino acid. To circumvent this, a fully-purified in vitro 
translation system was used with the pdCpA technology that did not include release 
factors (86). In addition, the use of purified in vitro translation system allowed the 
reprogramming of a sense codon (Val) on an engineered tRNAAsnB, designed to improve 
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the incorporation of unnatural amino acids (86). Yet, once again, significant differences 
in yield were reported. Yields with L-Ala of 93% were reported while N-methyl-Phe 
incorporated with a yield of 34%; D-Ala was undetected (87).  
 
Figure 1.8: Schematic of introducing unnatural amino acids into proteins. Stop codon 
suppressor tRNAs-CA are run-off transcribed and enzymatically ligated with the 
synthesized aa-pdCpa. A stop codon is introduced in the gene of interest on a plasmid, at 
the position where the unnatural amino acid is desired. Reproduced with permission from 
Noren et al. Science, 244, 182 (1989).  
 
A major breakthrough in misacylation of tRNAs with unnatural amino acids came 
with the flexizyme system developed by Suga and colleagues (13). The flexizyme (Fx) is 
a de novo ribozyme, developed by in vitro selection, that recognizes the 3’-XCCA end of 
tRNA, where X is the tRNA discriminator base; the Fx system can only recognize 
purines bases at that position. In addition, the flexizyme recognizes an aromatic ring of an 
activated amino acid. The ribozyme catalyzes the acylation of tRNA with the activated 
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amino acid (Figure 1.9). This allows for many classes of unnatural amino acids to be 
acylated onto fully modified tRNA in a direct, facile manner (14). 
 
Figure 1.9: : A) the dFx flexizyme. B) the eFx flexizyme. C) Compounds recognized by 
the Fx ribozymes. From left to right, dinitrobenzyl (DBE) active esters are recognized by 
dFx, cyanomethyl active esters (CME) and 4-chlorobenzyl active thioesters (CBT) are 
recognized by eFx. 
 
 
Two versions of the Fx were developed. The dFx ribozyme (dinitro-flexizyme) 
recognizes a dinitrobenzyl ester activated amino acid and is used for the acylation of non-
aromatic amino acids onto tRNA, as the amino acid does not contain an aromatic ring. 
The eFx ribozyme (enhanced-ribozyme) recognizes a cyanomethyl ester activated amino 
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acid and is used for the acylation of aromatic amino acids onto tRNA. In addition, eFx 
can recognize an amino acid activated with 4-chlorobenzyl thioester (CBT).  
 
 
1.5.2 Contribution of the tRNA body to translational fidelity 
Although the Adaptor Hypothesis ascribed a passive role to the tRNA body, there 
is growing evidence that the tRNA body contributes to translational fidelity. Perhaps the 
best known example is the Hirsh suppressor. Discovered in 1970, the Hirsh suppressor is 
a tRNATrp that contains a G24A mutation, located in the D-arm, changing a U11:G24 
base pair to a U11:A24. This mutation allows for tRNA to decode tryptophan as well as 
to read though a near-cognate stop codon (UGG to UGA) (88, 89).  
 
Figure 1.10: The Hirsh suppressor. This suppressor tRNA contains a G24A mutation in 
tRNATrp that allows it to read through a near-cognate stop codon. The mutation, shown in 
purple, is far from the tRNA anticodon. 
 
 
This mutation is far from the anticodon and therefore the tRNA body contributes to 
fidelity beyond the codon: anticodon pairing. Kinetic studies indicated that the Hirsh 
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suppressor is able to accelerate the forward rates of GTPase activation (k3 of the aa-tRNA 
selection kinetic scheme) and accommodation (k5 of the aa-tRNA selection kinetic 
scheme) at the near-cognate UGA codon (90) as is observed for cognate aa-tRNA. 
Crystallographic studies of the Hirsh suppressor showed stabilization of the distorted 
tRNA conformation while bound to EF-Tu during aa-tRNA selection (91) mimicking that 
observed for cognate aa-tRNA (the A/T conformation) (92). It has been a long-standing 
question of how the information of a cognate tRNA:mRNA pairing in the 30S is 
communicated to the 50S where ribosome-mediated GTP hydrolysis by EF-Tu takes 
place.  These results suggest that the means of relaying this information occurs via the 
tRNA body itself, thereby ascribing a more active role for the tRNA body than was 
initially envisioned.  
1.5.3 EF-P 
For many decades, the role of elongation factor P (EF-P) was unclear (eukaryotic 
eIF5A). EF-P is a non-essential protein that has contains a post-translational lysinylation 
at position K34 (93). Work by Ganoza and colleagues (94) was followed by crystal 
structure from the Steitz lab that implicated a role for EF-P in stimulating the first peptide 
bond between the initiator tRNA, fMet-tRNAfMet and an incoming acceptor (pmn) (95). 
Subsequently, two independent studies discovered a role for EF-P in assisting in the 
translation of proteins containing three prolines (PPP) or 2 prolines followed by a glycine 
(PPG), of which there are approximately 100 such proteins in E. coli (75, 76). These 
studies both showed that without EF-P present, E. coli ribosome stalls at these sites and 
produces truncated proteins and that addition of EF-P rescues the phenotype. Further 
studies expanded this result and showed that flanking amino acids around a PP (XPP or 
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PPX, where X is any amino acid) influence the extent of stalling that is then relieved by 
EF-P (96). There is evidence that Pro is a poor P-site substrate due to steric constraints 
and that the role of EF-P is to stabilize the 3’-CCA end of peptidyl-tRNA and optimize its 
position for nucleophilic attack (97). However, the questions of whether the amino acid 
or tRNA body causes stalling at polyproline stretches and how EF-P functions to rescue 
the stalled ribosomes remain unanswered.  
1.5.4 Peptidyl-tRNA dependent stalling mechanisms 
While most gene regulation in bacteria occurs at the level of transcription, there 
are several prokaryotic regulatory mechanisms that involve the ribosome. Perhaps the 
most notable are the nascent peptide-mediated arrest mechanisms which include tnaC 
(tryptophan sensing), the Erm classes (erythromycin sensing), and SecM classes of 
peptides (export monitoring). In each of these mechanisms, a leader peptide preceding the 
regulated gene contains a sequence of amino acids, that, along with the auxiliary 
molecule or signal, interact with the ribosome exit tunnel and PTC to arrest translation 
elongation (98, 99). Importantly, these are cis-acting mechanisms; the newly-translated 
peptide regulates the ribosome from within the PTC and ribosome exit tunnel. While each 
of these mechanisms share certain requirements and characteristics, they seem to function 
by different mechanisms. A mutation made at 23S rRNA nucleotide A751 abolished 
stalling for secM but did not relieve stalling for ErmC (100). However, mutation of exit 
tunnel nucleotides A2058U and A2503G and affected the efficiency of stalling for both 
(101). While contacts in the exit tunnel differ the function by allosterically inhibiting 
peptide bond formation at the PTC. For the sake of brevity, only the Erm genes are 
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discussed in detail here; chapters 2 and 3 will include further detail regarding SecM and 
tnaC.  
The antibiotic erythromycin and the macrolide class of antibiotics bind near the 
entrance of the ribosome exit tunnel where ribosomal proteins L4 and L22 form a 
constriction point (102, 103). The Erm-type genes (ErmC in E. coli) encode a 
methyltransferase that dimethylates 50S rRNA nucleotide A2058, thereby conferring 
resistance to the antibiotic erythromycin and other macrolide antibiotics. A sub-inhibitory 
concentration of erythromycin induces stalling of the 19 amino acid ErmC leader peptide 
(ErmCL), allowing for a conformational mRNA secondary structure that exposes a 
downstream Shine-Dalgarno site to allow for translation of the ErmC gene product (104). 
Only the first 9 residues are necessary for stalling (105) with a C-terminal sequence of 
IVFI (residues 6-9). Mutations of C-terminal peptidyl-IFVI abolish stalling completely. 
When these two conditions are met, the stalling is maintained no matter which aa-tRNA 
acceptor (or pmn) reacts with this sequence (104). Interestingly, the closely related 
ErmAL1 uses the C-terminal peptidyl sequence IAVV and stalling occurs when Glu-
tRNAGlu reacts with it; when Glu is mutated to Phe, the stalling is relieved (106).  
Another class of Erm-sensing stalling sequences is the RLR motif. Unlike the 
ErmCL and ErmAL peptides, the 3 amino acid sequence along with subinhibitory 
concentrations of macrolide, is sufficient to induce stalling. This sequence is too short to 
contact the antibiotic directly, thus there is an allosteric link between the antibiotic in the 
exit tunnel and the pairing of the donor and acceptor substrate in the PTC (107). 
Relatedly, a metagene analysis examining the general mechanism by which macrolide 
antibiotics inhibit translation was performed by the same group. They found that the 
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general mode of inhibition by the macrolide antibiotics is not to block exit of all peptides 
from extruding from the exit tunnel as was previously thought but rather the inhibition of 
peptide bond formation between specific donor and acceptor pairs (108).  
1.6 Conclusions 
The role of the amino acid in translation is considerably more complex than what 
was envisioned by the Adaptor Hypothesis. Indeed, the amino acid and the peptidyl 
tRNA affect every step of translation elongation from aa-tRNA selection (109), peptide 
bond formation (74, 110) and translocation (62). The tRNA body is more than an adaptor; 
its sequence and post-transcriptional modifications help determine its fidelity. Yet, how 
the ribosome responds to unnatural amino acids is only beginning to be understood. 
These next chapters will seek to integrate the background presented here to shed further 
light on how D-amino acids affect translation elongation.  
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2.1 Chapter outlook: 
Previous experiments performed by our group demonstrated that D-amino acids are 
selected by the ribosome and can successfully form a peptide bond with the initiator tRNA, 
fMet-tRNAfMet. However, once fMet-D-Phe-tRNAPhe has translocated into the P-site, it is 
impaired in forming the next peptide bond. We hypothesized that the P site-bound fMet-D-aa-
tRNA is interfering with the conformational rearrangements of the PTC that gate the chemistry 
of peptide bond formation. To test this, we employed a dimethyl sulfate (DMS)-based chemical 
probing assay and found that rRNA nucleotides A2058, A2059 and A2062 of the ribosome exit 
tunnel are found in an altered conformation when fMet-D-Phe-tRNAPhe is found in the P site as 
compared to fMet-L-Phe-tRNAPhe. This conformational change is allosteric because these 
nucleotides are too far from the fMet-D-Phe-tRNAPhe to be contacted directly. Thus, the 
ribosome is a conformation that correlates with a structure that does not support peptidyl transfer 
in the presence of fMet-D-Phe-tRNAPhe. In addition, nucleotide A2082 was likewise found to be 
in an altered conformation. This nucleotide is over 40Å from the PTC, suggesting that the fMet-
D-Phe-tRNAPhe causes long-range conformational changes within the 50S subunit.  
Molecular dynamics (MD) simulations were then performed and the results corroborated 
these findings. In addition, these experiments indicated that the P-site fMet-D-Phe-tRNAPhe has 
shifted 2Å away from the A-site aa-tRNA, suggesting a possible explanation for the defect in 
peptide bond formation observed. Finally, the MD simulations showed that the entire PTC is less 
conformationally mobile in the presence of fMet-D-Phe-tRNAPhe as compared to fMet-L-Phe-
tRNAPhe, suggesting that conformational mobility of the PTC is necessary to optimally catalyze 
peptide bond formation.  
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2.2 Introduction:  
 The ribosome catalyzes protein synthesis with L- or chiral amino acids. The speed and 
accuracy with which this process takes place has been studied extensively (1). However, few 
studies of the ribosome’s ability to utilize D-amino acids have been published. There are several 
motivations for studying the ribosome’s ability to incorporate D-amino acids. Firstly, there is 
considerable interest in protein engineering and in utilizing the ribosome in order synthesize 
novel polypeptides (2). A mechanistic understanding of how the ribosome handles unnatural 
amino acids such as D-amino acids would be valuable in improving this technology. Secondly, 
there is growing evidence that the TM contends with D-amino acids and must have the ability to 
exclude them from protein synthesis. D-amino acids are distributed widely throughout living 
organisms (3) and often found in bacteria in high concentrations (4). D-amino acids are 
synthesized by racemase enzymes in both in bacterial and yeast cells (5). In vitro experiments 
demonstrated that the Tyr-aaRS can charge D-Tyr as well as L-Tyr onto tRNATyr, though the rate 
of reaction is slower for D-Tyr (6, 7). This reaction was likewise shown to occur in vivo (8). The 
widespread distribution of D-aa-tRNA deacylases throughout the kingdoms of life demonstrates 
that D-aa-tRNAs present a challenge to the cell and possibly to the ribosome itself (9). Finally, 
unnatural aa-tRNAs and D-aa-tRNAs in particular, can be used as probes by which to parse out 
the mechanism of translation elongation. 
There are conflicting reports in the literature regarding the incorporation of D-amino 
acids. Yields reported vary from undetected to over 40% (10–12). Some of these studies were 
performed in cell extracts in which deacylase enzymes were not depleted while some were 
performed using a fully-purified in vitro system. In addition, differences in whether the tRNA 
used was engineered or post-transciptionally modified, the identity of the D-aa as well as 
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whether it suppressed a stop codon or reassigned a sense codon all play a role in determining the 
yields of the reaction. Motivated by the inconsistencies in yield and experimental design, 
experiments here were performed in a fully purified in vitro translation system, devoid of 
deacylase enzymes. The experimental design allowed for monitoring the ability of the D-aa-
tRNA to traverse the steps of translation elongation. D-aa-tRNAs are selected efficiently and can 
form dipeptide but are inhibited in forming tripeptide; the defect was mapped to the PTC.  
Here, we present a DMS-based chemical probing assay that was used to assess whether 
the defect in catalysis at the PTC is linked to a conformational change in the 23S rRNA. We 
found that nucleotides A2058, A2059, and A2062 of the entrance to the ribosome exit tunnel 
(ETE) are all in an altered conformation in the presence of a P site-bound fMet-(D-Phe)-
tRNAPhe. An all-atom MD simulation of a model system containing a P site-bound D-Phe 
likewise demonstrated this conformational change. The altered conformation observed here is 
very likely one that precludes optimal catalysis of peptidyl transfer at the PTC.  
2.3 Results:  
Previous experiments performed in our group determined that D-aa-tRNA is a substrate 
for the ribosome. L-Phe-tRNAPhe and D-Phe-tRNAPhe were each reacted with f-[35S]-Met-
tRNAfMet and the yields and rates were compared. In agreement with previously reported values 
(13), the yield of dipeptide conversion for L-Phe-tRNAPhe  was 87% at the 15s timepoint. D-Phe-
tRNAPhe was likewise capable of forming dipeptide with high yields, albeit with kapp of 0.02 s-1, 
three orders of magnitude slower than what is reported for protein synthesis in vitro (data not 
shown) (13). Once it was established that D-aa-tRNAs could serve as a peptidyl acceptor, we 
tested whether fMet-D-Phe-tRNAPhe could serve as a peptidyl donor. In line with previous 
reports (12), the tripeptide synthesis of fMet-(D-Phe)-Lys did not proceed to completion; the 
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reaction only reached a yield of 18% with an apparent rate of 0.004 s-1 (Figure 2.4c-d). A primer 
extension inhibition assay determined that a PRE complex of fMet-(D-Phe)-tRNAPhe is capable 
of translocating efficiently and a filter binding assay demonstrated that a POST complex of fMet-
(D-Phe)-tRNAPhe is stably bound to the ribosome and does not exhibit peptidyl-tRNA dropoff 
(data not shown).  A POST complex containing fMet-(D-Phe)-tRNAPhe was then reacted with 
pmn to assess whether the PTC is competent for catalyzing peptidyl transfer. Surprisingly, the 
final yield of this reaction was also 18% (data not shown). This result demonstrated that a P site-
bound fMet-(D-Phe)-tRNAPhe is impaired in acting as a peptidyl donor. The pmn experiment was 
likewise performed with fMet-(D-Val)-tRNAVal and fMet-(D-Lys)-tRNALys (data not shown) and 
the results demonstrated the previously observed impairment. In addition, these results suggested 
that the PTC may be in a conformation that does not support peptidyl transfer. It was 
hypothesized that structural rearrangements that are required for optimal catalysis of peptide 
bond formation by the PTC are somehow inhibited or altered in the presence of the peptidyl-D-
aa-tRNA (14).  
In order to compare potential secondary structure differences to the rRNA between fMet-
L-Phe-tRNAPhe and fMet-D-Phe-tRNAPhe, we utilized a DMS-based chemical probing assay. 
DMS is a methylating agent that reacts primarily with the N1 position of the adenine (A) base 
and to a lesser extent with the N3 position of the cytosine (C) base. Methylation of these 
positions can only occur when the base is exposed and not base paired. Thus, DMS probing can 
report on the secondary structure of nucleic acids (Fig. 2.1A) (15). A major innovation of DMS 
probing experiments came with the use of reverse transcriptase (RV) in analyzing positions of 
methylation (16, 17). In this type of experiment, DMS is used in limiting amounts such that, on 
average, a base is modified no more than one time. A radiolabeled primer is annealed to the 
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region of interest from where RV generates complementary DNA (cDNA). RV is blocked 1 
position upstream of a methylated A or C. This reaction generates a radiolabeled population of 
cDNAs of different lengths, depending on where RV was blocked from further reaction by a 
methyl group. The cDNAs are then separated on a denaturing polyacrylamide gel electrophoresis 
(dPAGE) gel; the stronger the band at a position, the more the base was exposed to methylation 
(Fig. 2.1B).  Between 85-100 nucleotides can be well resolved by dPAGE. Sanger sequencing 
lanes are used to establish the location of the modification or protection with nucleotide 
resolution.  
 
Figure 2.1: A) Chemical structures of (from top to bottom) DMS; adenine nucleoside methylated 
at the N1 position; cytosine nucleoside methylated at the N3 position. B) schematic of rRNA that 
has been methylated by DMS. A 5’-32P radiolabeled primer is annealed (shown in green) and RV 
generates a population of cDNAs (shown in purple), whose lengths are determined by the 
position of methylations, where RV falls off. These products are then separated by d-PAGE.  
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Chemical probing of the ribosome has been performed extensively and has been used to 
look at processes such as establishing antibiotic binding sites (18), monitoring tRNA binding and 
movement (19), and translation termination (20).  
In our experiments, four complexes were prepared. The first was a control POST 
complex containing fMet-L-Phe-tRNAPhe (-DMS) that was not exposed to DMS; this was would 
account for any natural structure to the rRNA that might block RV. The second was empty 
ribosomes exposed to DMS (-fMet). The third and fourth complexes were POST complexes 
containing fMet-L-Phe-tRNAPhe (L-complex) and fMet-D-Phe-tRNAPhe (D-complex). The 
translation reactions were allowed to proceed for 10 minutes at which time dipeptide has formed 
and translocated into the P site. After exposure to DMS, the rRNA was extracted in order to 
remove ribosomal proteins that would interfere with the RV reaction. The extraction is vigorous; 
therefore, the extracted rRNA was run on an agarose gel to ensure that no degradation of the 
rRNA occurred during the extraction process (Figure 2.2). Indeed, despite the conditions 
necessary for extraction, the 16S and 23S rRNA remained completely intact. 
 
Figure 2.2: 1% agarose gel of extracted rRNA complexes demonstrating that the rRNA remains 
intact following extraction. 




The design of the primers used in these experiments was based on what was done by 
Moazed and Noller (21). 17-nt DNA primers were used and named by the first nucleotide 
transcribed by RV; results obtained here with newly designed primers were confirmed with 
primers used in these earlier publications (see below) (22).  
 The first DMS chemical probing experiment performed was to assess whether peptidyl 
tRNA was translocated into the P site. Moazed and Noller showed that nucleotide A2439 is 
protected when tRNA is bound in the P site (22). Using Moazed and Noller primer 2493, we 
found that nucleotide A2439 was protected from methylation in the L- and D-complexes. 
However, in the -fMet complex, when no tRNA was present, nucleotide A2439 was exposed to 
modification, thus demonstrating that the L- and D-complexes contain P site-bound tRNA 
(Figure 2.3).   
 
Figure 2.3: DMS modification experiment demonstrating that tRNA is bound in the P site when 
nucleotide A2439 is protected. A strong natural pause site in the vicinity of A2451 precluded 
analysis of the residue. 




This region also contains nucleotide A2451, which in hydrogen bonding distance from 
the α-amine nucleophile of the peptidyl acceptor. This nucleotide has important implications in 
the protein shuttle model proposed for the mechanism of peptide bond form. Therefore, we were 
interesting in assessing whether this nucleotide was affected by the presence of fMet-D-Phe-
tRNAPhe in the P site, which could serve as a possible explanation for the low yields observed. 
However, a large natural pause site in the vicinity of A2451 precluded us from making any 
conclusions about this nucleotide.  
We next assessed the entrance of the ribosome exit tunnel (ETE) for any differences in 
the modification pattern between the L- and D-complexes. Using a newly designed primer, 2117, 
we found enhanced modification of nucleotides A2058 and A2059 in the D-complex as 
compared to the L-complex (Figure 2.7). In addition, we detected a modest enhancement of 
nucleotide A2062 in the D-complex. These nucleotides are approximately 10Å from fMet-(D-
Phe)-tRNAPhe, too far to be caused by a direct steric clash. Thus, the presence of P site-bound 
fMet-(D-Phe)-tRNAPhe allosterically induces a conformational change to the ETE. Nucleotides 
A2058, A2059 and A2062 have been implicated in several nascent peptide chain-mediated 
stalling mechanisms, indicating their importance in maintaining the ability of, or precluding the 
PTC from catalyzing peptidyl transfer. Thus, it is likely that the conformational change observed 
here is indicative of a conformation of the PTC that is a poor supporter of peptide bond 
formation.  




Figure 2.4: DMS probing experiment demonstrating that nucleotides A2058, A2059, A2062 
and A2082 exhibit enhanced modification in the presence of P site-bound fMet-(D-Phe)-
tRNAPhe. Lane 1, POST complex with fMet-(L-Phe)-tRNAPhe that was not exposed to DMS; 
Lane 2, empty ribosomes exposed to DMS; Lane 3, fMet-(L-Phe)-tRNAPhe POST complex 
exposed to DMS; Lane 4, fMet-(D-Phe)-tRNAPhe POST complex exposed to DMS.  
 
Interestingly, we also detected enhanced modification of nucleotide A2082. This nucleotide is 
over 40Å from the PTC in helix 75. Not only does the P site-bound fMet-(D-Phe)-tRNAPhe 
induce allosteric changes to its local environment, it also induces more distal changes to the 23S 
rRNA.  
We undertook a rigorous statistical analysis of the gels in order to confirm that the 
differences detected by eye corresponded to a true difference in intensity. Gels were scanned and 
visualized by phosphorimaging, and the resulting band intensities, which correspond to the 
average reactivity of each nucleotide with the chemical probe, were quantified and analyzed 
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using the semi-automated footprinting analysis (SAFA) software program (23). To normalize the 
fMet-L-Phe-tRNAPhe and fMet-D-Phe-tRNAPhe lanes to account for small potential differences in 
the total amount of radiolabeled cDNA that was loaded into each lane, we implemented a 
previously published approach using an algorithm that is built into SAFA (24). For each 
experiment, the algorithm compares the intensity of each band in the fMet-L-Phe-tRNAPhe lane 
with the intensity of the corresponding band in the fMet-D-Phe-tRNAPhe lane and identifies those 
bands that exhibit the smallest variations in intensity between the fMet-L-Phe-tRNAPhe lane and 
fMet-D-Phe-tRNAPhe lane (i.e., the invariant bands). Subsequently, for the set of invariant bands 
in each lane, the algorithm identifies those bands that are most tightly clustered around the 
median intensity of the set of invariant bands (i.e., such that high-intensity invariant bands 
occurring as a result of the reverse transcriptase encountering sequences at which it has a strong 
natural tendency to stop and low-intensity invariant bands that are too noisy to be confidently 
analyzed are excluded from the analysis) and ranks them in order by increasing dispersion from 
the median value. The intensities of the top-ranked invariant bands therefore (i) primarily reflect 
the chemical modification of the corresponding residues (as opposed to reflecting natural stops 
of the reverse transcriptase); (ii) are well above the noise such that they can be confidently 
analyzed; (iii) vary the least between the fMet-L-Phe-tRNAPhe and fMet-D-Phe-tRNAPhe lanes; 
and (iv) are the most similar to each other. Thus, small differences between the intensity of each 
top ranked invariant band in the fMet-L-Phe-tRNAPhe lane and its corresponding band in the 
fMet-D-Phe-tRNAPhe lane primarily reflect small differences in the total amount of radiolabeled 
cDNA that was loaded into each lane of the gel. The raw intensity of each band in each lane was 
then divided by the average intensity of the five top-ranked invariant bands in that lane to 
normalize the band intensities for small differences in the total amount of radiolabeled cDNA 
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that was loaded into each lane of the gel. The fMet-D-Phe-tRNAPhe lane was then set as the 
reference lane, and the normalized band intensities from the fMet-D-Phe-tRNAPhe lane were 
divided by the corresponding normalized band intensities from the same fMet-D-Phe-tRNAPhe 
lane, resulting in the calculation of a D/D ratio for each nucleotide that is equal to 1 and that 
serves as a reference. Subsequently, the normalized band intensities from the fMet-L-Phe-
tRNAPhe lane were divided by the corresponding normalized band intensities from the fMet-D-
Phe-tRNAPhe lane, resulting in the calculation of an L/D value for each nucleotide that reflects 
the difference in the DMS reactivity of that nucleotide in an EC carrying a P-site fMet-L-Phe-
tRNAPhe relative to an EC carrying a P-site fMet-D-Phe-tRNAPhe. The D/D ratio for each 
nucleotide (denoted by the black line connecting the filled black circles denoted as “D/D 
Reference” in Fig. 2.8) and the mean and SD of the L/D value for each nucleotide (denoted by 
the gray bars and corresponding black error bars labeled as “Mean L/D” in Fig. 2.8) were 
calculated from the three independent chemical probing experiments. To determine the 
significance of changes in the L/D value of each nucleotide, we compared the L/D value of each 
nucleotide to the average L/D ratio of all gel nucleotides (denoted as the red line labeled 
“Average L/D” in Fig. 2.8) and to the 1 and 2 SD uncertainty estimates (denoted by the red and 
orange dashed lines labeled “±1 SD From the Average L/D” and “±2 SD From the Average 
L/D,” respectively). A nucleotide that exhibits an L/D value that is above or below the average 
L/D is a nucleotide whose DMS reactivity is altered in an EC carrying a P-site fMet-L-Phe-
tRNAPhe relative to an EC carrying a P-site fMet-D-Phe-tRNAPhe. 




Figure 2.5: Statistical analysis of chemical probing d-PAGE gels. The band intensities for each 
rRNA nucleotide (2050–2085) from three independent chemical protection experiments were 
analyzed using SAFA software, and further data analysis was done as described in Chemical 
Probing Experiments. Gray bars depict the mean L/D intensity value for each nucleotide, and 
the corresponding black error bars depict the SD from the mean. The solid red line 
corresponds to the average L/D ratio of all gel nucleotides. The solid black line connecting 
filled black circles denotes the D/D ratio, which is a reference value. Dashed red lines 
correspond to ±1 SD from the mean, and dashed orange lines correspond to ±2 SDs from the 
mean. A change in nucleotide accessibility was considered statistically significant if the extent 
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 We then wanted to confirm these results with a primer designed by Moazed and Noller. 
The primer closest to our region of interest was primer 2274. This primer binds far from the 
region of interest and therefore we were required to run the gels for 5 hours in order to visualize 
the region, somewhat reducing the quality of the gels. However, as expected, the results obtained 
with primer 2274 were identical to the results obtained with our newly designed primer.  
 
Figure 2.6: DMS probing experiment analyzed with Moazed and Noller primer 2274. The 
results were identical to those of Fig. 2.5. 
 
In collaboration with the Schulten group, all-atom MD simulations were performed to 
gain further insight into how the P site-bound fMet-D-Phe-tRNAPhe affects the structure and 
dynamics of the PTC. A reduced system of the ribosome that included residues within 60Å of the 
PTC and only the acceptor stems of the tRNAs were modeled. The simulations were performed 
on two constructs; fMet-L-Phe-tRNAPhe in the P site and with Lys-tRNALys in the A site and the 
second with fMet-D-Phe-tRNAPhe in the P site and Lys-tRNALys in the A site. There are several 
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important findings of the MD simulations. Firstly, in line with the DMS probing experiments, the 
average conformations of nucleotides A2058, A2059 and A2062 are different in the fMet-D-Phe-
tRNAPhe construct as compared to the fMet-L-Phe-tRNAPhe construct. In addition, nucleotides 
G2505 and U2506, were likewise in an altered average conformation in the fMet-D-Phe-tRNAPhe 
construct, though this would not be detectable using DMS (Figure 2.7A). Secondly, the MD 
simulations showed that the distance between the nucleophilic α-amine of the Lys-tRNALys in 
the A site and and the electrophilic acyl group in the P site is farther apart in the fMet-D-Phe-
tRNAPhe construct by ~2Å (Figure 2.7B) . The reduced proximity of the the reacting moieties 
observed in the MD simulations may provides a plausible explanation for the difference in yield 
observed between the L- and D-complexes. Finally, the MD simulations found that the entire D-
complex is less flexible and conformationally mobile than the L-complex. This result suggests 
that conformational mobility is necessary for the PTC to optimally catalyze peptide bond 
formation.  
 
Figure 2.7: A) The average conformation of the rRNA nucleotides in the L- and D-complexes 
differs at nucleotides A2058, A2059, A2062, G2505, and U2506. rRNA in light purple and 
acceptor stems in black belong to the L-complex; Dark purple rRNA and gold acceptor stems 
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belong to the D-complex. B) Last 30 nanosecond trajectories of MD simulations demonstrate 
that the average distance between the reactive moieties in the D-complex is further apart than 
that of the L-complex. 
 
2.4 Discussion: 
 A DMS-based probing experiment was utilized to detect secondary structural changes to 
the ribosome in the presence of P site-bound fMet-D-Phe-tRNAPhe. We hypothesized that the C-
terminal D-Phe of the peptidyl tRNA in the P site may be interfering with conformational 
rearrangements of the PTC that are necessary for optimal catalysis. Interestingly, while we 
initially thought we would discover changes to the nucleotides in the immediate vicinity of the 
C-terminal D-Phe, we instead discovered that nucleotides A2058, A2059 and A2062 
demonstrate an enhanced exposure to DMS. These nucleotides are found in the ETE and are too 
far from the C-terminal D-Phe to be contacted directly. Indeed, a peptide of four amino acid 
residues would be necessary to contact A2062, of seven to contact A2059 and of nine to contact 
A2058 (25). Therefore, the P site-bound fMet-(D-Phe)-tRNAPhe induces this conformational 
change allosterically.  
The conformational change of the ETE observed here is very likely a conformation that 
limits the ability of the PTC to catalyze peptidyl transfer. DMS probing of ribosomes with the 
antibiotic chloramphenicol bound demonstrates enhancement of nucleotides A2058, A2059 and 
A2062, which is remarkably similar to what is observed here. This is not as a result of direct 
contact, as nucleotides A2451 and G2505 are protected from chemical probes, indicating that the 
binding site of the antibiotic is in the A site and not at the ETE (26, 27). In addition, the 
nucleotides that are altered in the D-complex are implicated in several nascent peptide-mediated 
translation arrest mechanisms. A2058 is critical for stalling the SecM leader peptide and 
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mutation of A2058 to another base abolishes stalling (28). A2058 and A2059 are likewise 
implicated in the stalling of the tnaC leader peptide (29, 30) and A2062 is necessary for stalling 
the ErmC leader peptide (31). In addition, a cryo-EM structure of a stalled SecM complex 
demonstrated that the C-terminal portion of the P site-bound peptidyl tRNA is shifted away from 
the A-site tRNA in a manner likewise observed in our MD simulations (32).  
In addition to the P site-bound fMet-(D-Phe)-tRNAPhe severely reducing the ability of the 
PTC to catalyze peptidyl transfer, it also allosterically induces a conformational change to the 
ETE. This raises the possibility that there is a function link or coupling between the PTC and the 
exit tunnel and that the P site-bound fMet-(D-Phe)-tRNAPhe stabilizes certain conformations of 
the ETE. For example, not only does chloramphenicol allosterically induce a conformational 
change to the ETE as was described above, mutations to the ETE result in resistance to the 
antibiotic (33, 34). At least one report has interpreted the chloramphenicol data as a 
conformational coupling between the PTC and the ETE and that the stabilization of a certain 
conformation of the PTC upon antibiotic binding likewise stabilizes a particular conformation of 
the ETE (27). Perhaps the most compelling evidence to date comes from Mankin and colleagues 
who demonstrated that binding of the antibiotic erythromycin in the ETE in conjunction with a 
short Arg-Lys-Arg peptide in the P site causes a conformational change to PTC nucleotide 
U2585 that inactivates the ribosome (35). The results presented here add a new dimension to the 
growing body of evidence of a linked PTC and ETE. 
Our results demonstrate that D-aa-tRNAs can arrest translation and provide a plausible 
explanation for the widespread distrubution of D-aa-tRNA deacylase enzymes. In addition, we 
have shown that the D-aa-tRNA can serve as a valuable tool to learn out new information about 
the PTC and peptidyl transfer. Finally, the mechanistic insight obtained here will be valuable in 
 Chapter 2: Peptidyl-D-aa-tRNAs allosterically induce conformational changes of the ribosome exit tunnel 
 
 55 
engineering the ribosome to better incorporate unnatural amino acids such as D-amino acids. A 
possible interpretation of our data is that engineering of ETE may improve incorporation of 
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 Chapter 3: The identity of the A-site aa-tRNA peptidyl acceptor 














3.1 Chapter outlook: 
We previously demonstrated that P site-bound peptidyl-D-aa-tRNAs cause a 
conformational change to the ribosome exit tunnel that correlates with a state of the PTC that is 
less competent for peptidyl transfer. Among the data presented there, the yield of the tripeptide 
synthesis reaction of fMet-(D-Lys)-Phe was 58% after one hour. However, the reaction of fMet-
(D-Lys) with pmn after one hour was only 9%. This discrepancy in the yield suggested the 
possibility that the yield of the tripeptide synthesis reaction with D-amino acids might be 
sensitive to the nature of the reacting peptidyl acceptor. In order to test this possibility, we 
reacted D-lys in the tripeptide synthesis reaction with four aa-tRNAs in the third position that 
differ in sterics and electrostatics. We found that the yield of the tripeptide synthesis reaction 
with D-Lys can be either high or low, depending on the nature of the peptidyl acceptor, with 
charged amino acids performing poorly and hydrophobic amino acids increasing the yield. These 
results suggest that the nature of the pairing of the aa-tRNA acceptor and the C-terminal D-
amino acid that is esterified to the P site-bound peptidyl-tRNA can either promote or suppress 















The ribosome has evolved to work with 20 amino acids that are esterified onto tRNAs, 
many of which exist as several isoforms. Thus, the ribosome must be able to accept multiple 
substrates and efficiently catalyze peptide bond formation with all them. It was thought that, by 
analogy, the incorporation of unnatural amino acids would not pose a serious challenge to the 
TM. However, many classes of unnatural amino acids incorporate with poor efficiency, if at all. 
While some classes of unnatural amino acids bind poorly to EF-Tu (1), other classes, such as D-
amino acid, stall the ribosome at the PTC (2). The mechanism by which these unnatural amino 
acids stall the PTC remains unknown. 
Previously, our group demonstrated that the tripeptide reaction to form fMet-(D-Phe)-
Lys, fMet-(D-Lys)-Phe and fMet-(D-Val)-Lys formed with yields of 18%, 11%, and 58% 
respectively. While the reaction of fMet-(D-Phe) and fMet-(D-Val) with pmn proceeded with 
yields that matched the yields obtained with full-length aa-tRNA, the yield of fMet-(D-Lys) with 
pmn was only 9%, which stands in stark contrast to the yield obtained for tripeptide with D-Lys 
and full-length aa-tRNA. Given that pmn is a tyrosine analog and the high yield of tripeptide 
with D-Lys was obtained with Phe-tRNAPhe as the third amino acid, we hypothesized that the 
yield of the tripeptide reaction with D-amino acids has a dependency on the the nature of the 
reacting peptidyl acceptor. We chose four different aa-tRNAs whose structures differ by 
hydrophobicity (Phe-tRNAPhe), branching (Val-tRNAVal), and electrostatics (Glu-tRNAGlu and 
Arg-tRNAArg) and reacted it in the tripeptide reaction with D-Lys (Figure 3.1).  






Figure 3.1: Experimental setup of the tripeptide reaction. 70S ribosomes initiated with 35S-
labeled fMet were reacted in one pot with L- or D-Lys in the second position and either Phe, 
Val, Glu or Arg in the third position. The products of the reaction were separated by 
electrophoretic thin layer chromatography (eTLC). 
 
We discovered the stalling observed with peptidyl-Lys-tRNALys could be modulated 
depending on the identity of the peptidyl acceptor. The charged aa-tRNAs we tested exacerbated 
D-amino acid-mediated ribosomal stalling while hydrophobic amino acids relieved it. By testing 
the misacylated Phe-tRNAGlu in the tripeptide reaction with D-Lys, we found that the yield of the 
reaction was significantly improved over the correctly acylated Phe-tRNAPhe. These experiments 
extend our understanding of the mechanism of D-amino acid mediated stalling. In addition, these 
results provide important insight into ways to improve the incorporation of unnatural amino 
acids into proteins by the ribosome.  
3.3 Results 
  We first translated fMet-(L/D-Lys)-Phe to recapitulate earlier results. As was reported 
earlier, fMet-D-Lys-Phe formed tripeptide at 58% after one hour. This is close to the tripeptide 





yield obtained for the natural fMet-L-Lys-Phe. We confirmed that in our hands, the kapp of 
tripeptide formation for fMet-(D-Lys)-Phe is 0.024 s-1, in line with what was reported earlier. As 
described previously, this rate seems to be determined primarily by the slow formation of fMet-
(D-Lys) dipeptide. However, more studies will be required to determine and interpret rates with 
D-amino acids.  
 
 
Figure 3.2: A) representative eTLC separating the products of the tripeptide reaction of fMet-(L-
Lys)-Phe and fMet-(D-Lys)-Phe. The tripeptide reactions with L-Lys and D-Lys were performed 
side-by-side in duplicate. ImageQuant© software was used in analysis of the data. B) The 
timecourses were fit to a single exponential function to determine the kapp of the reaction using 
GraphPad Prism© software.  
 
 
We next tested how Arg-tRNAArg performed in the tripeptide reaction. Surprisingly, we 
found that the tripeptide reaction was severely inhibited with Arg (Figure 3.3). In fact, very little 
product formed during our observation period (60 min). This results stands in stark contrast to 































kapp(D-Lys)=0.024 s-1  ±  0.002





acceptor is capable of modulating the yield of the tripeptide reaction. One might have expected 
that, given enough time, Arg-tRNAArg would continuously be allowed to the bind to the A site 
and eventually, enough productive peptidyltransfer events would take place for the tripeptide 
reaction to proceed to completion. Yet, the reaction plateaus at an early timepoint with a low 
yield and Arg-tRNAArg is unable to rescue the stalled ribosomes. Thus, one possible 
interpretation of these data is that the Arg-tRNAArg becomes lodged in the A site due to a 
structural change that leads to incorrect accommodation into the ribosomal A site. The aa-tRNA 
that is incorrectly accommodated cannot serve as a competent peptidyl acceptor and in addition, 
occludes the A site from binding other aa-tRNAs.  
 
 
Figure 3.3: Tripeptide reactions of fMet-(L/D-Lys)-Arg. A) Representative eTLC of the reaction 
demonstrates that very little product forms over the observation period of 60 minutes. B) Plot of 
the fMet-(L-Lys)-Arg and fMet-(D-Lys)-Arg reactions. 
 
Following this result, we tested Glu-tRNAGlu. We likewise observed significant stalling 




































timecourse to confirm that the reaction had proceeded to completion. The yield for fMet-(D-
Lys)-Glu was 21% after one hour. This result, along with the result of Arg-tRNAArg 
demonstrates that charged amino acids exacerbate D-amino acid-mediated stalling.  
 
Figure 3.4: Tripeptide reactions of fMet-(L/D-Lys)-Glu. A) Representative eTLC of the reaction 
and B) plot of the timecourse demonstrate that little reaction forms over the observation period 
of 60 minutes, but substantially more than that of fMet-(L/D-Lys)-Arg 
We then looked at whether Val-tRNAVal would relieve or worsen stalling in the tripeptide 
reaction with D-Lys. Val is a sterically bulky amino acid due to branching at the β-carbon that 
could further affect the already hampered activity of the PTC. To our surprise, we observed that 
the reaction of fMet-(D-Lys)-Val proceeds extremely quickly with high yields. Due to technical 
issues, we were not able to quantify this result accurately. However, our initial analysis indicated 
that the fMet-(D-Lys)-Val reaction is complete within the first 15s. If true, this indicates that Val 
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Figure 3.5: Tripeptide reactions of fMet-(L/D-Lys)-Val. Technical difficulties separating the 
products precluded making definitive conclusions about tripeptide formation of fMet-(D-Lys)-
Val. 
 
We were interested in whether the effect of the peptidyl acceptor that we observed is due 
to the amino acid or the tRNA body. We generated a misacyated Phe-tRNAGlu and hypothesized 
that the amino acid plays the dominant role in inducing or relieving stalling. As we expected, 
since Phe-tRNAPhe served as an amino acid that relieved stalling, Phe-tRNAGlu likewise relieved 
stalling. However, the yield of the reaction with Phe-tRNAGlu is significantly improved relative 
to Phe-tRNAPhe (Figure 3.6). Thus, it seems that both the amino acid and the tRNA body 
contribute to relieving or inducing ribosomal stalling with D-Lys. Indeed, the synergistic effect 
of the amino acid and the tRNA body to the substrate specificity of the TM has been well-
established (3, 4). This result suggests that engineering the entire aminoacyl-tRNA acceptor may 

























Figure 3.6: Figure 3.6: Tripeptide reaction with a misacylated Phe-tRNAGlu in the third position. 
In our experiments, fMet-(D-Lys)-Phe formed tripeptide with high yields whereas fMet-(D-Lys)-
Glu formed tripeptide with low yields. This result demonstrates that the effect of the peptidyl 
acceptor on the reaction with fMet-(D-Lys) is dependent on both the amino acid and the tRNA 
body.  
3.4 Discussion: 
Here, we describe the dependency of D-aa-mediated ribosome stalling at the PTC on the 
identity of the third amino acid. Previously, the tripeptide reaction to form fMet-(D-Lys)-Phe 
was shown to proceed with a final yield of 60% after one hour, which approaches the yield of its 
natural counterpart, fMet-(L-Lys)-Phe. In contrast, the yields of fMet-(D-Phe)-Lys and of fMet-
(D-Val)-Lys were 18% and 11% after one hour, respectively. The interpretation of these results 
was that peptidyl transfer with D-amino acids displays a side-chain dependence (5). Using the 
best performing D-aa, D-Lys, we reacted it with 4 amino acids that vary by hydrophobicity, 
sterics and electronics to test whether the tripeptide yield of D-aa’s is dependent on the identity 
of the reacting A-site aa-tRNA. We found that, indeed, the yield of the tripeptide reaction could 


































D-tripeptide Yield (% at 60 
minutes) 
fMet-(D-Lys)-Phe 64.4 ± 0.5 
fMet-(D-Lys)-Arg 6.4 ± 1.5 
fMet-(D-Lys)-Glu 21.1 ± 2.8 
fMet-(D-Lys)-Val >64.4 
fMet-(D-Lys)-Phe-tRNAGlu 93 
Table 3.1: Summary of results  
We previously demonstrated by chemical probing that the entrance of the ribosome exit 
tunnel undergoes a conformational change in response to a P site-bound fMet-(D-Phe)-tRNAPhe. 
Specifically, we identified A2058 and A2059 as nucleotides that are affected by fMet-(D-Phe)-
tRNAPhe. These nucleotides are also implicated in several nascent peptide chain-mediated arrest 
mechanisms, notably the erm class. The erm cassette is a group of inducible erythromycin-
resistance genes, the most well-known of which is ErmC. The ErmC gene is preceded by a leader 
peptide, ermCL, which stalls in the presence of subinhibitory concentrations of erythromycin. 
The stalled leader peptide then allows for a conformational rearrangement that exposes the SD of 
ermC, allowing for the expression of the methyltransferase that methylates A2058, reducing the 
affinity of the antibiotic to its binding site. Mankin and coworkers demonstrated that the 
efficiency of stalling of the related ErmAL1 leader peptide was dependent on the aa-tRNA 
acceptor reacting with the stalling sequence in the P site. Stalling was exacerbated with charged 
aa-tRNAs and reduced with hydrophobic aa-tRNAs (6).  Surprisingly, the reactivity profile for 
stalling with ErmAL1 falls very closely in line with what we observed in the tripeptide reaction 
with D-lys. This suggests that D-amino acid mediated ribosome stalling is closely related to a 
mechanism of stalling that is found in Nature (Figure 3.7). 
 
 






Figure 3.7: Reactivity profile reported of the stalled ErmAL1 leader peptide reported in Ramu, 
H. et al. (6) (Reproduced with permission). The amino acids tested in the tripeptide reaction with 
D-Lys are circled in red. 
We propose a modified mechanistic model of stalling with D-aa’s. Initially, we proposed 
that the P site bound fMet-D-aa partitions the PTC into an active and inactive population. The 
active population is able to continue catalyzing peptidyl transfer unaffected while the inactive 
form cannot proceed. However, the results presented here indicate that the nature of the peptidyl 
acceptor can modulate the rate and extent of tripeptide formation. Thus, we propose to modify 
the model to suggest that the pairing of the A and P site tRNAs induces a conformation that is 
productive or not productive for peptidyl transfer. When the pairing is productive, proper 
accommodation takes place that allows for the correct alignment of the substrates and successful 
peptidyl transfer. When the pairing is not productive, the induced conformation causes 
accommodation to be distorted and the A site tRNA to be bound incorrectly in the PTC. This not 
only causes a defect in peptidyl transfer, it also causes the A site tRNA to remain bound, 





occluding the A site from aa-tRNAs from binding. This has been demonstrated in the cryo-EM 
structure of ErmBL leader peptide (7). There, the peptidyl acceptor, Lys-tRNALys remains bound 
in the A site throughout the complex purification, though it is bound in a conformation that is 
unproductive for peptidyl transfer. The altered contacts made by the peptidyl acceptor and its 
inability to react demonstrates that improper accommodation took place. If the aa-tRNA acceptor 
easily dissociated from the A site, then another aa-tRNA could bind again and attempt peptidyl 
transfer. Eventually, all the reactions would reach completion. However, the data presented here 
all plateau and do not proceed. This suggests that the A site is occluded due to structural 
rearrangements at the PTC that are dependent on the pairing of the P site-bound fMet-(D-Lys) 
and the nature of the reacting peptidyl acceptor. 
A series of papers have probed the mechanism of erythromycin on protein synthesis. 
Initially, it was thought that the binding of erythromycin at the entrance of the ribosome exit 
tunnel acts as a ‘bottle stopper’ that did not allow the growing peptide chain to exit the tunnel, 
leading to peptidyl tRNA dropoff (8, 9). It was then discovered that a subset of the proteome 
continues to be translated despite having a macrolide antibiotic bound in the exit tunnel (10). A 
ribosome profiling analysis showed that protein synthesis continues until specific pairings of 
peptidyl donors and acceptors are encountered that lead to translation arrest (11). These effects 
may become more pronounced when something is altered in the region of the PTC, for example, 
the binding of a small molecule. It is also possible that whatever is leading to the effects with 
erythromycin is also leading to the altered reactivity seen with D-Lys and may be generalizable 
to other classes of unnatural amino acids. Indeed, the incorporation of β-amino acids was vastly 
improved when several regions flanking the PTC, including that of A2058 and A2059 were 
mutated (12, 13), making them resistant to erythromycin. Expressing these erythromycin-





resistant ribosomes in E. coli allowed for the incorporation of β-amino acids into a protein in 
vivo (14). This provides anecdotal evidence that the connection we have made between 
erythromycin and stalling with D-amino acids is indeed correct. Thus, D-amino acids can be 
used as a means to probe the mechanism of the peptidyl transfer reaction without the need for 
auxiliary small molecules. 
Finally, it is possible that the incorporation of other classes of unnatural amino acids 
follow a similar pattern of behavior as the D-amino acids. If true, then increasing the yield of 
incorporation of unnatural amino acids may be as simple as altering the next amino acid without 
the need for engineering the TM. In addition, our results suggest that engineering the tRNA body 
of the aa-tRNA acceptor could also greatly improve the incorporation of unnatural amino acids. 
The results presented here as well as in the previous chapter suggest that engineering allostery 
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4.1  mRNA Preparation 
 
4.1.1 mRNA constructs 
The mRNAs used in the studies described in this thesis were all in vitro transcribed using 
well-established protocols (1–3). They are all mutants of the T4gp321-20 mRNA (this is a 
truncated version of the wild-type T4gp321-225) and plasmids containing the mutagenized 
construsts were made by subcloning. Two fragments were amplified, each one using two 
primers: one primer to the wild-type plasmid and the second one with an overhang containing the 
desired mutagenic sequence. The two resulting fragments were then fused via fusion PCR using 
Vent polymerase. The resultant fragment was then ligated into a pUC119 vector and the desired 
product was identified by colony PCR and sequencing.  
Table 4.1: Primers used for mutagenesis  
Primer name  Sequence Mutations 
pUC119 forward (outside 
primer) 
GCC AGG GTT TTC CCA GTC ACG AC N/A 
pUC119 reverse (outside 
primer) 
CAC AGG AAA CAG CTA TGA CCA TGA 
TTA C 
N/A 
fMet-Lys-Phe-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG AAA TTT C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
AAA TTT 
CCT 
fMet-Lys-Phe-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGA AAT TTC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Lys-Arg-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG AAA CGT C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
AAA CGT 
CCT 
fMet-Lys-Arg-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGA CGT TTC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Lys-Glu-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG AAA GAA C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
AAA GAA 
CCT 
fMet-Lys-Glu-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA  




GGT TCT TTC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
fMet-Lys-Val-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG AAA GTG C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
AAA GTG 
CCT 
fMet-Lys-Val-Pro reverse  GCA GCG AGT TCA GCA GTA GAT TTA 
GGC ACT TTC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Phe-Lys-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG TTT AAA C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
TTT AAA 
CCT 
fMet-Phe-Lys-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGT TTA AAC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Phe-Glu-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG TTT GAA C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
TTT GAA 
CCT 
fMet-Phe-Glu-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGT TCA AAC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Phe-Val-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG TTT GTG C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
TTT GTG 
CCT 
fMet-Phe-Val-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGC ACA AAC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Val-Lys-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG GTG AAA C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
GTG AAA 
CCT 
fMet-Val-Lys-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGT TTC ACC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Val-Glu-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG GTG GAA C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
GTG GAA 
CCT 
fMet-Val-Glu-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGT TCC ACC ATT TTT ATT TCC TTA 
GGG CCC TGT G 
 
fMet-Val-Phe-Pro forward CAC AGG GCC CTA AGG AAA TAA AAA 
TG GTG TTT C CTA AAT CTA CTG CTG 
AAC TCG CTG C 
GTG TTT 
CCT 
fMet-Val-Phe-Pro reverse GCA GCG AGT TCA GCA GTA GAT TTA 
GGA AAC ACC ATT TTT ATT TCC TTA 








4.1.2 Plasmid linearization 
 Plasmids containing the desired mRNA were purified by Maxi prep (Qiagen) and 100µg 
was digested using the BamH1-high fidelity restriction endonuclease (New England Biolabs). 
The digest reaction was then subjected to a phenol-chloroform extraction, precipitated, and 
resuspended in 50µL of ddH2O. The linearized plasmid served as the template for in vitro 
transcription.  
4.1.3 In vitro transcription 
 In vitro transcription employed purified T7 RNA polymerase. NTP mix was made from 
the individual solid NTPs to a final concentration of 50uM at pH 7 (stored at -80C°).  
10x T7 buffer (stored at -80C) 






Transcription reactions were set up on a 100uL scale under the following conditions: 





4mM of each NTP 
0.1µM DNA template 
20 units/µL T7 RNA polymerase 
 
Reactions were incubated for 3 hours at 37 C°. Reactions should become cloudy due to the 
formation of pyrophosphate magnesium salts. Reactions were spun down once an hour. After 2 
hours of reaction, 0.1 units/µL DNAse I (New England Biolabs) was added and allowed to 
incubate for 1 hour at 37C°. Reactions were quenched with 80mM EDTA. Reactions were buffer 
exchanged into water along with removal of excess NTPs. Purity was assessed by a 10% D-
PAGE stained with 0.05% toluidine blue stain (Figure 4.1).  





Figure 4.1: 10% D-PAGE gel of analytical runoff transcription reactions 
 
4.2 tRNA aminoacylation 
tRNAs were either aminoacylated using a purified aminoacyl tRNA synthetase (aaRS) or 
the dFx/eFx ribozyme developed in the Suga lab (4). tRNAs were purified from E. coli and 
purchased either from Sigma or MP Biomedicals. 
4.2.1 Synthetase chargings 
4.2.1.1 tRNAfMet with [35S]-Methionine 
Preparation of 5:10-methenyltetrahydrofolate 
Formation of 5:10-methenyltetrahydrofolate from folinic acid is chemically prepared from 
folinic acid (Acros Organic) as previously described (3). This is used as the formyl donor 
substrate for tRNAfMet formyltransferase. This is stored at -80C° until ready for use.  








 5:10-methenyltetrahydrofolate must be converted to 10N-formyltetrahydrofolate (10-
FTHF), as this is the active substrate for the tRNAfMet formyltransferase.  
10uL of 14µM 5:10 methenyltetrahydrofolate 
1uL 1M KOH 
0.5µL 1M Tris-HCl pH 8 
 
React at room temperature for 15 minutes. Reaction should be clear and almost colorless after 
addition of KOH. If it looks cloudy, this means the THF has degraded and should not be used.  
5x AF buffer 
Mix together the following and then filter through a 0.22µm filter 
 
625 µL 1 M Tris-HCl, pH37C°=7.5 
35.7 µL 4.9 M MgCl2 
1875 µL 2 M KCl 
5 µL 0.5 M EDTA 
25 µL 1 M DTT 
1250 µL 50 mM ATP 
1184 µL nanopure water 
 
Reaction setup: 
35S-labed methionine is charged onto fMet-tRNAfMet is side-by-side with non-
radiolabeled methionine (with 80 µM final concentration of methionine). The charging 
efficiency is determined by FPLC. 
35S-methionine Reaction: Methionine reaction: 
20µL 5x AF buffer ([1x] final) 10µL 5x AF buffer ([1x] final) 
10.2µL of 197µM tRNA fMet ([20µM] 
final) 
5.1µL of 197µM tRNA fMet ([20µM] 
final) 
36µL 35S Met (8.6µM)  N/A 
2.5µL of 10-FTHF ([300 µM] final) 1.25µL of 10-FTHF ([300 µM] final) 
1.6µL of 10mM cold Met (only add after 5 
minutes of reaction) 
0.95µL of 10mM cold Met 
26.4µL ddH2O 31.1µL ddH2O 
0.3µL of 6.9µM MetRS ([0.02µM] final) 0.15µL of 6.9uM MetRS ([0.02µM] final) 
3uL of 6.6uM Transformylase ([0.2µM] 
final) 
1.5uL of 6.6uM Transformylase ([0.2µM] 
final) 
100uL total 50uL total 
 




Allow reaction to proceed at 37C° for 10 minutes. After 10 minutes, dilute the cold sample with 
50L degassed ddH2O with DTT (for ease of extraction).  Extract 2x with 100µL Phenol, 
followed by 100µL Chloroform.  At each addition step of the solvent, vortex and centrifuge for 
1-2 minutes.  To the aqueous layer, add 3M NaOAc pH 5 to 0.3M (1/10 of total extracted 
volume).  To this, add 3x volume ice cold Ethanol, shake, and allow to precipitate overnight at -
80C°.  Do all these steps on ice and make sure that the centrifuge is at 4C°.  After overnight 
precipitation, spin the samples at 14,000 rpm for 20 minutes.  Remove the supernatant, being 
careful not to disturb the pellet.  Wash the pellet with 70% Ethanol by adding it to the pellet and 
spinning at 14000 rpm for 2 minutes.  Remove the 70% Ethanol and allow the pellet to dry in the 
cold room for 10 minutes. Following this, dissolve the pellet in 35mL 10mM KOAc pH 5.  This 
will be put through a P6 column (Biorad) that has been buffer exchanged in 10mM KOAc pH 5.  
(manufacturer’s directions).  After this, take the concentration of the sample using an extinction 
coefficient of 726,700 M-1cm-1 at 260 nm. Use the cold sample to determine the charging 
efficiency by hydrophobic interaction chromatography (HIC) using a linear gradient of 0-100% 
Buffer B (Figure 4.2).   
HIC Buffers 
Buffer A 
1.7M Ammonium chloride 
10mM Ammonium acetate pH 6.3 
 
Buffer B 
10mM Ammonium acetate pH 6.3 
10% MeOH 
 





Figure 4.2: Representative trace of HIC analysis of fMet-tRNAfMet charging efficiency. The 
major peak at ~32 minutes corresponds to fMet-tRNAfMet. 
4.2.1.2 Aminoacylation of Phe-tRNAPhe, Lys-tRNALys and Arg-tRNAArg 
 The aminoacylation of Phe-tRNAPhe, Lys-tRNALys and Arg-tRNAArg is performed as 
described below. The aaRSs were purified from overexpressing strains of E. coli as described 
elsewhere.  
Reagent [Final] 
1M Tris HCl pH 7.5 200mM 
2M KCl 25mM 
1M MgCl2 15mM 
1M BME 2mM 
0.1M ATP 5mM 




tRNA Lys 113.7uM 15µM 
2mM Lysine 56µM 
Lys aaRS 0.75µM 
 
Incubate the reaction at 37C° for 10 minutes. After the incubation, add 0.3M NaOAc pH 5 to 
quench the reaction. Extract once with Phenol and once with Chloroform (all done at 4 C°). Add 
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3x ice-cold 100% EtOH and precipitate at -80 C° overnight. After overnight precipitation, spin at 
14000 rpm for 30 minutes at 4C°. Let the pellet dry in cold room for 10 minutes. Resuspend the 
pellet in 35µL (for 100µL reaction) 10mM KOAc pH 5. Buffer exchange through a P6 column 
that has been buffer exchanged with 10mM KOAc pH 5. Take concentration, make aliquots, and 
flash freeze. 
 The charging efficiency of Phe-tRNAPhe is determined by HIC, analogously to that of 
fMet-tRNAfMet  (Figure 4.3).  
 
Figure 4.3: Representative trace of HIC analysis of Phe-tRNAPhe charging efficiency. The major 
peak at ~47 minutes corresponds to Phe-tRNAPhe. 
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Lys-tRNALys and Arg-tRNAArg are not adequately separated by HIC and the charging efficiency 
is determined by 6% denaturing acid-PAGE.  
6% denaturing acid-PAGE: 
Gels are run using 16 cm x 24 cm plates for 16h at 4C° at 190V. The running buffer is 0.3M 
NaOAc pH5 that is prechilled. Note that 100 pmol of sample will be necessary to see on the gel.  
6% denaturing acid-PAGE: 
15.5 mL ddH2O 
6.1 mL 40% Acrylamide/Bis solution 19:1 
1.25 mL 3 M NaOAc, pH 5 
18 g Urea 
0.5 mL 10% APS 
25 µL TEMED 
 
1.5x Urea/NaOAc/XC loading buffer:  
8 M Urea 
0.1 M NaOAc, pH 5.0 
0.05% XC 
 
After running the gel, stain with 0.05% toluidine blue for 1 minute at room temperature. Remove 
stain and destain with water (Figure 4.4).  
 
 









4.2.1.3 Aminoacylation of Glu-tRNAGlu and Val-tRNAVal 
 
Reagent [Final] 
5x AF buffer 1x 
tRNAVal 20µM 
Valine amino acid 80mM 
Val aaRS 0.02µM 
 
Reactions were performed in an identical manner to the aminoacylations of Phe-tRNAPhe, Lys-
tRNALys and Arg-tRNAArg.  
4.2.2 Aminoacylation with Flexizyme  
4.2.2.1 Synthesis of amino acid active esters 
Representative protocol for the synthesis of DBE substrates (L-Lysine-3,5-dinitrobenzyl ester):  
A mixture of α-N-Boc-L-Lysine (300 mg, 1.6 mmol), DBE chloride (286 mg, 1.3 mmol), 
Triethylamine (270 mg, 2.7 mmol) and in 2.0 mL of DMF was allowed to react at room 
temperature overnight. Diethylether (30 mL) was added and the solution was extracted with 0.5 
M HCl (10 mL x 3), 4% NaHCO3 (10 mL x 3) and brine (20 mL x1). The organic layer was 
isolated and dried with MgSO4 and concentrated. The resulting crude residue was dissolved in 8 
mL of 4 N HCl/EtOAc in order to remove the Boc protecting group and stirred for 20 min at 
room temperature. The solution was concentrated once again. The remaining HCl was removed 
by high vacuum. The product was precipitated by the addition of a diethyl ether:methanol 
mixture (10:1 v/v), and the precipitate was filtered in 30% overall yield. The product was further 
purified by semi-preparative HPLC using a gradient of 1%MeCN and 0.1%TFA to 80%MeCN 
















Figure 4.5: 1D-NMR of L-Lys-DBE. 1H NMR (CD3OD) δ(ppm): 9.03 (t, J = 2.0 Hz, 1H, aryl-
C3-H), 8.73 (d, J = 2.0 Hz, 2H, aryl-C1-H), 5.56 (s, 2H, O-CH2-), 4.24 (t, J = 6.4 Hz, 1H, Ca-H), 








































Representative protocol for the synthesis of CME substrates (L-Phenylalanine-cyanomethyl 
ester): A mixture of α-N-Boc-L-Phenylalanine (265 mg, 1 mmol), Proton Sponge (429 mg, 2 
mmol) and cyanomethyl chloride (1mL, excess) in 2.0 mL of dry DMF was stirred under inert 
atmosphere at room temperature overnight. Ethyl acetate (36 mL) was added to the reaction. The 
resulting solution was extracted as described for the DBE synthesis. The Boc protecting group 
was removed as described above. The product was obtained in 35% overall yield (125 mg, 0.47 
mmol). The product was further purified by semi-preparative HPLC as described for the DBEs. 
4.2.2.2 Ribozyme aminoacylation 
The aminoacylation reactions with the ribozyme contained 20 µM tRNA, 20 µM dFx or 
eFx, and 5 mM amino acid-DBE or CME substrate, respectively in a buffer of 0.1 M HEPES-K 
(pH25°C = 7.5), 0.1 M KCl, 600 mM MgCl2, and 20% DMSO (4). Aminoacylations of tRNAPhe 
and tRNALys with D/L-Phe-CME and D/L-Lys-DBE, respectively, proceeded for 2 hours on ice. 
All aminoacylation reactions were quenched with 3 volumes of 600 mM ammonium acetate, pH 
5 followed by precipitation with ethanol. The aa-tRNAs were resuspended and stored in 10 mM 
potassium acetate pH 5 at –80 ºC, and were used without further purification. 
4.2.2.3 32P-labeling of 3’-end of tRNA 
 In order to assess the aminoacylation efficiency of the ribozyme reaction, analytical 
aminoacylations with 32P-labeled 3’-end of tRNA were performed side-by-side with the 
preparative scale reaction under identical conditions. The 3’-end of tRNA was 32P-labeled with 
[32P]-AMP using nucleotidyl transferase as previously described (5, 6). The aminoacylation 
reaction was performed as described above. The resuspended aa-tRNAs were digested with P1 
nuclease (Sigma) for 10 minutes at room temperature. The separation of [32P]-AMP from aa-
[32P]-AMP was achieved by thin-layer chromatography (TLC) on polyethyleneimine-
impregnated (PEI)-cellulose plates (EMD Chemicals, Inc) with a running buffer of 100 mM 




ammonium chloride, 10% acetic acid (6). TLC plates were exposed to a phosphorimaging screen 
(GE Healthcare Life Sciences) overnight and imaged by phosphor imager. The intensities of 
TLC spots corresponding to the unreacted [32P]-AMP (I[32P]-AMP) and to aminoacylated product 
(Iaa-[32P]-AMP) were quantified using ImageQuant© software. Aminoacylation efficiencies were 
calculated as (Iaa-[32P]-AMP)/ (((I[32P]-AMP) +(Iaa-[32P]-AMP)) ⋅ 100 (Figure 4.6).  
 









































4.3 Fully purified in vitro translation system 
4.3.1 Purification of 70S ribosomes 
 Tightly coupled E. coli 70S ribosomes were purified from the MRE 600 strain by sucrose 
density gradient ultracentrifugation as previously described (3, 7). The purified ribosomes were 
stored in a buffer containing 10 mM Tris-acetate (pH25°C = 7.5), 60 mM ammonium chloride, 7.5 
mM magnesium acetate, 0.5 mM EDTA, 6 mM BME, and 40% sucrose at –80 C° (Figure 4.7). 
 
Figure 4.7: Analysis of sucrose gradients. Tightly coupled 70S ribosomes are separated from free 
30S and 50S subunits by UV analysis of sucrose density gradients. 
4.3.2 Purification of translation factors 
 Initiation factors IF-1, IF-2 and IF-3, elongation factors EF-Tu, EF-Ts, and EF-G were 
purified as previously described (3, 8). Strains overexpressing 6xHis tagged factors with a TEV 








4.3.3 Tris-Polymix buffer for tripeptide synthesis 
Peptide synthesis reactions were performed in a Tris-Polymix Buffer containing 50 mM 
Tris-acetate (pH25°C = 7.5), 100 mM KCl, 0.5 mM calcium acetate, 5 mM ammonium acetate, 3.5 
mM magnesium acetate, 6 mM BME, 1 mM spermidine and 5 mM putrescine (3, 8, 9).  
4.3.4 Ribosomal Initiation complexes 
70S tightly coupled ribosomes, initiation factors IF-1, IF-2 and IF-3 as well as GTP were 
incubated for 10 min at 37 Cº. mRNA was then added, followed by a second incubation at 37 Cº 
for 10 min. Finally, f-[35S]Met-tRNAfMet was added. The mixture was incubated for a third time 
at 37 ºC for 10 min and once prepared, was stored on ice until use. The initiation complexes did 
not undergo further purification and were made fresh in each experiment. The concentration of 
Mg2+ was never allowed to be lower than 3.5mM at any step. Low Mg2+ concentration leads to 
dissociation of the ribosomal subunits. 
T4gp321-20 mRNAs were used to form all ribosomal initiation complexes used in the 
peptide synthesis reactions. All of the messages were mutated to contain the coding sequence of 
interest as well as Pro in the fourth position (Pro was not translated). The description of these 
messages is in this chapter, section 4.1. 
4.3.5 aa-tRNA⋅EF-Tu(GTP) ternary complex formation and EF-G preparation  
aa-tRNA⋅EF-Tu(GTP) ternary complexes were prepared in the following way: EF-Tu, 
EF-Ts and GTP and polymix buffer were mixed and incubated at 37 ºC for 1 min and cooled on 
ice for 1 min. The aa-tRNAs were then added and the mixture was incubated again for 1 min at 
37 Cº. The complexes were stored on ice until use. The ternary complexes were made fresh for 
each experiment. 




EF-G was prepared as a separate mixture. EF-G was mixed with GTP, 
phosphoenolpyruvate, and pyruvate kinase. This mixture was not incubated but was stored on ice 
without further purification until ready for use.  
4.3.6 Peptide synthesis reactions 
 Prior to beginning the tripeptide synthesis reaction, the EF-G mixture was combined with 
the initiation complex. The reaction was initiated with the addition of the aa-tRNA⋅EF-Tu(GTP) 
ternary complex containing the ribozyme-aminoacylated L- or D-aa-tRNAs as well as a 
synthetase-charged aa-tRNA in the third position if called for. The final concentrations in the 
tripeptide reactions were the following: [70S ribosomes] = 0.5µM, [f-[35S]-Met-tRNAfMet] = 
0.25µM, [IF-1] = 0.75µM, [IF-2] = 0.75µM, [IF-3] = 0.75µM, [mRNA] = 3µM, [EF-Tu] = 
10µM, [EF-Ts] = 3µM, [EF-G] = 1.5µM, [L/D-aa-tRNA (ribozyme, second position)] = 1µM, 
[aa-tRNA (synthetase, third position)] = 1µM, [GTP] = 0.5mM, [Mg2+] = 3.5mM. 
Concentrations in the initiation complexes, ternary complexes and EF-G complexes were all 
calculated to obtain these concentrations in the final reaction mixture. For timecourses, samples 
were taken from the reaction mixture at the indicated timepoints and quenched with KOH to a 
final concentration of 125mM.  
For the fMet-(L/D-Lys)-Arg reactions, approximately 0.5µL of the quenched reaction 
was spotted onto a cellulose TLC plates (EMD) and products were separated using 
electrophoretic thin layer chromatography (eTLC) in pyridine acetate buffer (5% pyridine, 20% 
acetic acid, pH = 2.8) (10). Briefly, the reactions were spotted in the center of the plate. The plate 
was wetted with pyridine acetate buffer from each end towards the center, carefully applying the 
solvent so as not to disturb the spotted products. Once completely wetted but not oversaturated, 
the plates were carefully placed in the eTLC chamber, with one end of the plate towards the 




positive node and the other end of the plate towards the negative node. The buffer should not 
reach the first inch of the plate. In order to insure that the plate does not dry out, the chamber is 
filled with Stoddard Solvent to completely cover the plate.  
For reactions involving fMet-(L/D-Lys)-Phe, fMet-(L/D-Lys)-Glu and fMet-(L/D-Lys)-
Val, the samples from the timecourses were diluted twofold and 0.4µL was spotted on the 
cellulose TLC plates. The plates were then run for one hour at 800V. For reactions involving 
fMet-(L/D-Lys)-Arg, 0.4µL of the quenched timecourse sample was spotted and eTLCs were run 
for 30 minutes at 1200 V. In all cases, eTLCs were then dried, exposed to a phosphorimaging 
screen overnight, and analyzed by phosphor imager.  
The intensities of eTLC spots corresponding to di- and tripeptide products (Idi, Itri, and 
were quantified using ImageQuant® software. Percent tripeptide was calculated as (Itri)/( Idi + 
Itri)⋅ 100. Percent tripeptide as a function of time was fit to a single exponential function using 
GraphPad Prism. Experiments were performed in duplicate and the standard error between 
measurements was reported. 
4.4 Chemical Probing with DMS (10, 11, 12) 
 
Dipeptide synthesis reactions to produce elongation complexes (ECs) carrying either 
fMet-L-Phe-tRNAPhe or fMet-D-Phe-tRNAPhe at the P site were prepared as described in Section 
4.3.6 with exceptions of the final concentrations: [70S ribosomes] = 0.5 µM; [mRNA] = 1.9 µM; 
[EF-Tu] = 10 µM; [D/L-aa-tRNA (ribozyme, second position)] = 1.0 µM; [L-aa-tRNA, 
synthetase, third position] = 1.0 µM; [EF-G] = 1.7 µM. The final concentration of fMet-tRNAfMet 
in complexes containing dipeptidyl-tRNA in the P site was adjusted to 0.75 µM to ensure that 
70S ribosomes were the limiting reagent. Dipeptide synthesis reactions involving L-Phe-tRNAPhe 




and D-Phe-tRNAPhe were allowed to proceed for 2.5 minutes and 10 minutes, respectively. These 
dipeptide synthesis reaction times ensured that the dipeptide synthesis reactions had gone to 
completion and the resulting dipeptidyl-tRNAs had been fully translocated into the P site. 
Control reactions containing vacant ribosomes (i.e. not carrying any tRNAs) rather than ECs 
were prepared identically to that described in section 4.3.6, with the exception that acylated 
tRNAs were omitted.  
Following the incubation times listed in the previous paragraph, dimethyl sulfate (DMS)  
chemical probing reactions were performed using slight modifications of a previously published 
protocol (13). DMS was diluted 10-fold with DMS Buffer (80% ethanol in Tris-Polymix Buffer) 
immediately before use. DMS modification of ECs was initiated by adding 1 µL of the diluted 
DMS solution to the ECs. Upon addition of DMS, the ECs were immediately placed on ice and 
incubated for 45 minutes. Four DMS chemical probing reactions were performed during each 
experiment: (1) ECs containing fMet-L-Phe-tRNAPhe in the P site were treated with DMS buffer 
lacking DMS, (2) vacant ribosomes were treated with DMS (3) ECs containing fMet-L-Phe-
tRNAPhe were treated with DMS and (4) ECs containing fMet-D-Phe-tRNAPhe were treated with 
DMS.  25 ng of glycogen (Ambion) was added to all reactions immediately prior to precipitating 
the ribosomal RNA (rRNA) with 95% ethanol.  Following ethanol precipitation, pellets 
containing the precipitated rRNA were dissolved in 200µL of a solution consisting of 0.3 M 
NaOAc, 2.5 mM EDTA, and 0.5% SDS. The resulting solution was extracted with phenol 3 
times with vigorous agitation for 5 minutes followed by chloroform extraction 2 times with 
vigorous agitation for 3 minutes. Following the phenol and chloroform extractions, the rRNA 
was ethanol precipitated a second time. The resulting pellets were dissolved in 15 µL NanoPure 
H2O.  




A 17-nucleotide DNA primer complementary to 23S rRNA in the region of A2058 and 
A2059 in the PTC and named for the first 23S rRNA nucleotide that is reverse transcribed 
(Primer 2117: 5’-CAAAGCCTCCCACCTAT-3’) was radiolabeled with γ-[32P]-ATP and 
polynucleotide kinase as described previously (14). Additional 17-nucleotide DNA primers 
complementary to 23S rRNA that were tested, but that did not reveal reactivity differences in the 
presence of a P-site peptidyl-D-aa-tRNA, included Primer 2639, Primer 2493, and Primer 800, 
which probe the regions surrounding 23S rRNA nucleotides A2602, A2451, and A751, 
respectively, in the PTC. To anneal the 32P-labeled DNA primer to the 23S rRNA, a reaction 
mixture containing ~1.0 pmol rRNA and 0.7 pmol [32P]-labeled DNA primer in Sequencing 
Buffer (25 mM Tris-HCl (pH25ºC = 8.3)), 40 mM KCl, and 5 mM MgCl2) was incubated for 5 
minutes at 65 ºC (final volume = 10 µL) and then slow cooled to room temperature on the 
benchtop. A mixture of deoxynucleotides at a final concentration of 500 µM of each 
deoxynucleotide in Sequencing Buffer and 18 Units of AMV reverse transcriptase were then 
added to the primer-annealed 23S rRNA samples and the resulting primer extension reactions 
(final volume = 20 µL) were incubated at 42 °C for 30 minutes. Sequencing reactions were 
performed using rRNA that was isolated from unmodified vacant ribosomes in a manner that was 
identical to that isolated from ECs and were run in a manner identical to that for the primer 
extension reactions with the exception that 25 uM of specific dideoxynucleotides were included 
in the mixture of deoxynucleotides. Primer extension and sequencing reactions were quenched 
with an equal reaction volume of Gel Loading Buffer (23 M formamide, 0.09% bromophenol 
blue, and 0.09% xylene cyanol) and the cDNA products were separated using gel electrophoresis 
on a 7% denaturing polyacrylamide gel.  
Buffers and Reaction Mixes 
 




10X Sequencing Mix: 
400mM KCl 
250mM Tris-HCl, pH 8.3 
50mM MgCl2 
 
dNTP Sequencing Mix: 
10uL 10X sequencing Mix 




dNTP + ddATP Sequencing Mix: 
10uL 10X sequencing Mix 
10uL 10mM dNTP mix (10mM dATP, 10mM dTTP, 10mM dGTP, 10mM dCTP) 




dNTP + ddTTP Sequencing Mix: 
10uL 10X sequencing Mix 
10uL 10mM dNTP mix (10mM dATP, 10mM dTTP, 10mM dGTP, 10mM dCTP) 




dNTP + ddGTP Sequencing Mix: 
10uL 10X sequencing Mix 
10uL 10mM dNTP mix (10mM dATP, 10mM dTTP, 10mM dGTP, 10mM dCTP) 




dNTP + ddCTP Sequencing Mix: 
10uL 10X sequencing Mix 
10uL 10mM dNTP mix (10mM dATP, 10mM dTTP, 10mM dGTP, 10mM dCTP) 
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